Actively Recruiting
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
Led by Wuerzburg University Hospital · Updated on 2025-04-03
55
Participants Needed
1
Research Sites
137 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.
CONDITIONS
Official Title
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals 18 years of age or older
- Clinical diagnosis of primary open angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma
- Uncontrolled intraocular pressure with maximally tolerated medical therapy
- Progressive thinning of retinal nerve fiber layer assessed by spectral domain optical coherence tomography (p < 0.05)
- Progression of visual field defects
- Presence of visually significant cataract and indication to reduce intraocular pressure or glaucoma medication burden
You will not qualify if you...
- Clinical diagnosis of neovascular glaucoma, angle-closure glaucoma, or uveitic glaucoma
- Prior glaucoma surgery
- Preexisting conditions affecting episcleral venous pressure such as Grave's ophthalmopathy, Sturge-Weber syndrome, or arteriovenous fistulas (carotid-cavernous fistula)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Uniklinikum Würzburg
Würzburg, Bavaria, Germany, 97080
Actively Recruiting
Research Team
R
Raoul Verma-Fuehring, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here